Skip to main content

CORRECTION article

Front. Pharmacol., 07 December 2023
Sec. Gastrointestinal and Hepatic Pharmacology
Volume 14 - 2023 | https://doi.org/10.3389/fphar.2023.1330698

Corrigendum: Study on the pathogenesis of MiR-6324 regulating diarrheal irritable bowel syndrome and bioinformatics analysis

This article is a correction to:

  1. Study on the pathogenesis of MiR-6324 regulating diarrheal irritable bowel syndrome and bioinformatics analysis

    1. Read original article
Jin XiaoJin Xiao1Yan-ni ZhouYan-ni Zhou2Yan-lin YangYan-lin Yang3Li HeLi He4Ke-kai WangKe-kai Wang1Min Chen Min Chen1*
  • 1Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China
  • 2Sichuan Hospital of Integrative Medicine TCM, Chengdu, Sichuan, China
  • 3Zigong Fifth People’s Hospital, Zigong, Sichuan, China
  • 4Traditional Chinese Medicine Hospital, Chongqing, China

A Corrigendum on
Study on the pathogenesis of MiR-6324 regulating diarrheal irritable bowel syndrome and bioinformatics analysis

by Xiao J, Zhou Y-n, Yang Y-l, He L, Wang K-k and Chen M (2023). Front. Pharmacol. 14:1044330. doi: 10.3389/fphar.2023.1044330

In the published article, there was an error in Affiliation for author Chen Min. Instead of “Chengdu University of Chinese Medicine School of Clinical Medicine, Sichuan Provincial Hospital of TCM, Chengdu, Sichuan, China,” their affiliation should be “Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China.”

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: miR-6324, irritable bowel syndrome, bioinformatics analysis, pathogenesis, R language

Citation: Xiao J, Zhou Y-n, Yang Y-l, He L, Wang K-k and Chen M (2023) Corrigendum: Study on the pathogenesis of MiR-6324 regulating diarrheal irritable bowel syndrome and bioinformatics analysis. Front. Pharmacol. 14:1330698. doi: 10.3389/fphar.2023.1330698

Received: 31 October 2023; Accepted: 30 November 2023;
Published: 07 December 2023.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2023 Xiao, Zhou, Yang, He, Wang and Chen. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Min Chen, Y21AY2R1dGNtLmVkdS5jbg==

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.